Julie A Johnson
Título
Citado por
Citado por
Año
Estimation of the Warfarin dose with clinical and pharmacogenetic data
JJA Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MTM, Limdi NA ...
N Engl J Med 360, 753-64, 2009
1615*2009
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
BF Gage, C Eby, JA Johnson, E Deych, MJ Rieder, PM Ridker, ...
Clinical Pharmacology & Therapeutics 84 (3), 326-331, 2008
8762008
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
SA Scott, K Sangkuhl, CM Stein, JS Hulot, JL Mega, DM Roden, TE Klein, ...
Clinical Pharmacology & Therapeutics 94 (3), 317-323, 2013
7982013
A pharmacogenetic versus a clinical algorithm for warfarin dosing
SE Kimmel, B French, SE Kasner, JA Johnson, JL Anderson, BF Gage, ...
New England Journal of Medicine 369 (24), 2283-2293, 2013
7462013
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
6702011
CYP4F2 genetic variant alters required warfarin dose
MD Caldwell, T Awad, JA Johnson, BF Gage, M Falkowski, P Gardina, ...
Blood, The Journal of the American Society of Hematology 111 (8), 4106-4112, 2008
5962008
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes
R Malik, G Chauhan, M Traylor, M Sargurupremraj, Y Okada, A Mishra, ...
Nature genetics 50 (4), 524-537, 2018
5472018
PHARMACOGENOMICS: The Inherited Basis for Interindividual Differences in Drug Response
WE Evans, JA Johnson
Annual review of genomics and human genetics 2 (1), 9-39, 2001
5412001
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy
SA Scott, K Sangkuhl, EE Gardner, CM Stein, JS Hulot, JA Johnson, ...
Clinical Pharmacology & Therapeutics 90 (2), 328-332, 2011
4842011
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
GM Cooper, JA Johnson, TY Langaee, H Feng, IB Stanaway, UI Schwarz, ...
Blood, The Journal of the American Society of Hematology 112 (4), 1022-1027, 2008
4782008
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update
JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017
3752017
β1‐Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol
JA Johnson, I Zineh, BJ Puckett, SP McGorray, HN Yarandi, DF Pauly
Clinical Pharmacology & Therapeutics 74 (1), 44-52, 2003
3672003
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3827-3834, 2010
3612010
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements
CL Aquilante, TY Langaee, LM Lopez, HN Yarandi, JS Tromberg, ...
Clinical Pharmacology & Therapeutics 79 (4), 291-302, 2006
3612006
Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics
JJ Lima, DB Thomason, MHN Mohamed, LV Eberle, TH Self, JA Johnson
Clinical Pharmacology & Therapeutics 65 (5), 519-525, 1999
3301999
The pharmacogenetics research network: from SNP discovery to clinical drug response
KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ...
Clinical Pharmacology & Therapeutics 81 (3), 328-345, 2007
2832007
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci
FW Asselbergs, Y Guo, EPA Van Iperen, S Sivapalaratnam, V Tragante, ...
The American Journal of Human Genetics 91 (5), 823-838, 2012
2822012
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci
R Saxena, CC Elbers, Y Guo, I Peter, TR Gaunt, JL Mega, MB Lanktree, ...
The American Journal of Human Genetics 90 (3), 410-425, 2012
2822012
Pharmacogenomics: challenges and opportunities
DM Roden, RB Altman, NL Benowitz, DA Flockhart, KM Giacomini, ...
Annals of internal medicine 145 (10), 749-757, 2006
2792006
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients
HJ Eisen, J Kobashigawa, A Keogh, R Bourge, D Renlund, R Mentzer, ...
The Journal of heart and lung transplantation 24 (5), 517-525, 2005
2632005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20